论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Cheng N, Guo Y
Received 15 September 2017
Accepted for publication 6 November 2017
Published 11 December 2017 Volume 2017:10 Pages 5843—5853
DOI https://doi.org/10.2147/OTT.S151800
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 2
Editor who approved publication: Dr William Cho
Abstract: Nasopharyngeal
carcinoma (NPC) is one of the most common malignancies and seriously endangers
people’s health. Recently, long noncoding RNA (lncRNA) NEAT1 has been determined as
an oncogenic gene in a variety of cancers. However, the effect of NEAT1 in NPC
and its underlying mechanism have not been well elaborated. In this study, the
data showed that NEAT1 was upregulated and miR-124 was downregulated in NPC
tissues and cells. Loss-of-function revealed that NEAT1 knockdown inhibited
proliferation and promoted apoptosis of NPC cells while gain-of-function
revealed that upregulated NEAT1 showed an opposite effect. Moreover, NEAT1 was
demonstrated to suppress miR-124 expression by direct interaction in NPC cells.
Additionally, miR-124 reversed NEAT1-mediated pro-proliferation and
anti-apoptosis effect. Furthermore, miR-124 regulated NPC cell proliferation
and apoptosis via NF-κB signal pathway. Mouse models of NPC confirmed that
NEAT1 overexpression facilitated tumor growth by modulating miR-124 in vivo.
Taken together, this study indicated that upregulated NEAT1 promoted the
tumorigenesis and progression of NPC through regulating miR-124/NF-κB signaling
pathway, suggesting an attractive therapy target for NPC patients.
Keywords: nasopharyngeal
carcinoma, lncRNA, NEAT1, miR-124, NF-κB pathway